Search  in | Advanced
   Print  
Correspondence

This section contains letters that have been sent by AABB on issues of concern to the transfusion medicine and cellular therapies communities. Click on a link below to read the latest correspondence.

Letter to FDA from the AABB Ad Hoc Task Force to Propose an Alternate Post-Market Study Design for Seven-Day Platelets – 4/28/08
FDA Response to Letter from AABB Bacterial Contamination Standard Task Force to FDA on Approval Strategies for Point-of-Release Testing for Bacterial Contamination – 4/24/08
Letter to the FDA Nominating Industry Representatives to BPAC – 2/28/08
Letter to the FDA on a Draft Template for a Shorter Inter-donation Interval During an Influenza Pandemic – 2/14/08
Follow up to the Letter from AABB Bacterial Contamination Standard Task Force to Gambro BCT and Fenwal in Response to the Discontinuation of the Passport Study – 2/13/08
Letter to FACT Proposing Accreditation Partnership – 2/4/08
Letter from AABB Bacterial Contamination Standard Task Force to Gambro BCT and Fenwal in Response to the Discontinuation of the Passport Study - 1/31/08
Letter from AABB Bacterial Contamination Standard Task Force to FDA on Approval Strategies for Point-of-Release Testing for Bacterial Contamination - 12/26/07
Letter to the AMA on Cord Blood Banking - 11/16/07
Letter to Verax Biomedical, Inc. Regarding the Platelet PGD® Test - 10/3/07 (PDF)
Letter to HHS on the Appointment of the Advisory Council on Blood Stem Cell Transplantation - 10/2/07
Letter to CMS Requesting Proper Categorization of the eBDS Test System - 9/14/07
Letter to FDA in Response to the Report of the Human Tissue Task Force - 7/6/07
Letter and Proposal to FDA on Component Plasma Licensure - 4/10/07
Letter to Facilities Selected for Inclusion in 2007 NBCUS - 3/7/07 (PDF)
Last modified on 5/6/2008 10:49:33 AM
What's New!
Call for AABB Award Nominations
Details
2008 AABB Annual Meeting & TXPO Online
Details
AABB Weekly Report - October 3, 2008
Details
AABB Announces 2008 Award and Scholarship Recipients
Details
The National Blood Foundation (NBF) Announces Recipients of the 2008 NBF Scientific Research Grants
Details
Association Bulletin #08-04 - Strategies to Reduce Adverse Reactions and Injuries in Younger Donors
Details
Summary of Draft Comments to be Submitted to TJC on Blood Management Performance Measures
Details
Significant Changes to the Standards for Cellular Therapy Product Services, 3rd edition
Details
First Ever National Biovigilance Network in the U.S. Reaches $1 Million in Funding, Prepares for Fall Pilot Launch
Details
2008 West Nile Virus Biovigilance Network
Details
List of AABB-Accredited Facilities with Approved Variances for ISBT 128
Details
Instructions on Applying for an AABB Variance
Details